What happens to your body when you stop taking Wegovy

Appetite hormones suppressed during treatment tend to reactivate once the medicine clears your system, often within weeks.
Clinical trials show that most participants regained the majority of lost weight within a year of stopping, according to data from the STEP programme.
Weight regain is a recognised biological response, not a sign of poor willpower or failed treatment.
Stopping abruptly is generally safe medically, but a conversation with your prescriber first gives you the best chance of managing what comes next.

When you stop taking Wegovy, most people regain a significant portion of the weight they lost, and the biological signals that drove appetite before treatment tend to return. That is not a personal failing. Clinical evidence shows that semaglutide works by suppressing appetite hormones that are genuinely active in the brain, and those hormones do not simply switch off when the course ends. This is a prescription-only medicine, and any decision to stop or pause should involve the prescriber who oversees your treatment, because the timing and how you approach it matters. The NHS guidance on semaglutide makes this point directly.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why regain happens, how quickly it unfolds, and what the evidence actually says

The myth that stopping is straightforward — and what the trials found instead

The most common assumption people make is that the weight loss achieved during Wegovy treatment is permanent, or at least that it holds for a good while after stopping. The trial data tells a different story. In the STEP 1 extension study, participants who had lost around 15% of their body weight over 68 weeks regained roughly two-thirds of that within a year of discontinuing semaglutide 2.4mg, returning to close to their pre-treatment baseline by the study's end. That figure is not a reason to feel defeated. It reflects something straightforward: Wegovy is a treatment for a chronic condition, not a finite course for a curable one.

The reason the weight returns is rooted in how the medicine works. Semaglutide activates GLP-1 receptors in the brain and gut that regulate hunger, satiety and the rate at which the stomach empties. While you are taking it, those signals are modulated. When the medicine clears your system, usually over a few weeks given semaglutide's roughly one-week half-life, the underlying physiology reasserts itself. Hunger increases. The sense of fullness after a meal diminishes. Energy intake rises. The body also has strong metabolic defences against weight loss — counter-regulatory mechanisms that were never addressed by the medicine in the first place and which resume once it is gone. None of this is unique to Wegovy; it reflects what we now understand about obesity as a chronic biological condition rather than a lifestyle choice.

What your body experiences in the weeks after your last dose

Most people notice the change gradually. In the first week or two after stopping, the appetite-suppressing effect fades as semaglutide levels drop. For some, the return of hunger feels quite sudden after months of finding it easy to eat less. Food thoughts become more persistent. Portion sizes that felt comfortable during treatment may feel insufficient. Some people also notice that nausea and other gastrointestinal effects, if they were still present at a low level, resolve completely, which is expected and welcome.

Metabolic rate does not drop dramatically overnight, but the weight lost during treatment included some lean mass alongside fat, and that can reduce resting energy needs modestly. The combination of increased appetite and slightly lower metabolic requirement creates the conditions for weight to return steadily. Blood sugar markers, blood pressure readings, and cholesterol levels that improved during treatment may begin to move back towards pre-treatment values over several months, depending on how much weight is regained. If you had a weight-related condition that benefited from treatment, it is worth discussing that trajectory with your GP or prescriber before stopping, not after. Our frequently asked questions cover some of the practical questions people ask at this stage.

If you stopped Wegovy for a short period rather than altogether, the effects of a two-week break are somewhat different from a full discontinuation, and worth reading about separately.

Stopping because of side effects or cost, and whether restarting is possible

People stop Wegovy for different reasons. Side effects are common, particularly gastrointestinal ones like nausea, vomiting, and constipation, and for some they never fully settle despite a slow titration schedule. Cost is a real factor too: private treatment is an ongoing commitment, and understanding exactly what Wegovy involves as a longer-term treatment helps set realistic expectations before starting. Others stop because they feel they have reached their goal and want to test what happens next.

Restarting is medically possible in most cases. If weight regain is significant, a prescriber can assess whether resuming treatment makes clinical sense. The titration schedule would typically restart from the beginning to allow the body to readjust, though this depends on how long the gap has been and individual circumstances. Some people move to a lower maintenance dose to balance tolerability and effectiveness long-term. None of this is a decision to make alone. A prescriber who knows your history (your weight trend, your comorbidities, your previous response to the medicine) is in a far better position to advise than a general article can be.

If you are thinking about restarting, or about beginning for the first time, the private route to Wegovy in the UK goes through a clinical assessment, not a checkout. Every repeat at nume is reviewed by a real clinician before anything is dispensed. When your treatment is approved, it arrives the next working day via DPD, in plain unbranded packaging, no indication on the box of what is inside.

Practical steps that can slow the rate of regain

The evidence does not offer a magic solution for maintaining weight after stopping, but it does point to factors that help. Protein intake matters more than most people realise: adequate protein preserves lean mass during any period of calorie deficit or weight change, which in turn supports a more stable metabolic rate. Strength-based physical activity has a similar effect. The NHS Better Health guidance on weight management is a sensible foundation, even for people transitioning off a GLP-1 medicine.

Keeping the eating patterns formed during treatment, smaller portions, slower eating, more attention to hunger cues, tends to be easier than it sounds for a while, because the habits built over months of lower appetite are at least partially embedded. But hunger does return, and if you want to understand what happens after you stop taking Wegovy in more detail, reading about the physiological changes can help you plan realistically rather than hoping things will stay the same. Structured support, whether from a GP, a dietitian, or a specialist service, helps significantly more than informal willpower. If you are considering stopping and want to understand the broader picture of weight management options, the treatment overview at nume outlines what is available to UK adults through a private clinical route. The full guide to stopping Wegovy covers the clinical detail in more depth for anyone who wants to read further before making a decision, and there is also a focused resource on what happens when you stop taking Wegovy specifically for weight loss, which addresses the question from a body composition and metabolic angle.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions